Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.4.1.7EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.4.1.7EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.4.1.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.4.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.80EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.80EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.80ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.80ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.80EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.80EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.80ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.80ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.134EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.134EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.134ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.134ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.134EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.134EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.134ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.134ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CZ.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CZ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CZ.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CZ.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CZ.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CZ.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CZ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CZ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.377EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.377EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.377ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.377ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.377EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.377EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.377ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.377ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.15EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.258.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.15ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.258.15ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.258.15EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.258.15EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.258.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.298EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.298EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.298ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.298ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.298EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.298EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used